Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Plos One|December 11, 2012
Evaluation of peripheral blood mononuclear cell processing and analysis for Survival Motor Neuron proteinDione T Kobayashi, Douglas Decker, Phillip Zaworski, et al.Assay and Drug Development Technologies|August 23, 2014
Assays for the identification and prioritization of drug candidates for spinal muscular atrophyJonathan J Cherry, Dione T Kobayashi, Maureen M Lynes, et al.Plos One|September 10, 2011
Utility of survival motor neuron ELISA for spinal muscular atrophy clinical and preclinical analysesDione T Kobayashi, Rory J Olson, Laurel Sly, et al.Plos One|December 2, 2016
Normalization of Patient-Identified Plasma Biomarkers in SMNΔ7 Mice following Postnatal SMN RestorationW David Arnold, Sandra Duque, Chitra C Iyer, et al.Plos One|May 5, 2012
Candidate proteins, metabolites and transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) clinical studyRichard S Finkel, Thomas O Crawford, Kathryn J Swoboda, et al.Plos One|May 5, 2012
Evaluation of SMN protein, transcript, and copy number in the biomarkers for spinal muscular atrophy (BforSMA) clinical studyThomas O Crawford, Sergey V Paushkin, Dione T Kobayashi, et al.Plos One|April 9, 2013
SMA-MAP: a plasma protein panel for spinal muscular atrophyDione T Kobayashi, Jing Shi, Laurie Stephen, et al.Biorxiv : the Preprint Server for Biology|January 14, 2021
Immunogenicity of an AAV-based, room-temperature stable, single dose COVID-19 vaccine in mice and non-human primatesNerea Zabaleta, Wenlong Dai, Urja Bhatt, et al.Cell Host & Microbe|August 24, 2021
An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primatesNerea Zabaleta, Wenlong Dai, Urja Bhatt, et al.Pageof 1